572
Views
18
CrossRef citations to date
0
Altmetric
Review

Prevention of sudden unexpected death in epilepsy: current status and future perspectives

, , , &
Pages 497-508 | Received 26 Feb 2020, Accepted 07 Apr 2020, Published online: 26 Apr 2020

References

  • Nashef L, So EL, Ryvlin P, et al. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia. 2012;53:227–233.
  • Fazel S, Wolf A, Långström N, et al. Premature mortality in epilepsy and the role of psychiatric comorbidity: A total population study. Lancet. 2013;382:1646–1654.
  • Harden C, Tomson T, Gloss D, et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the guideline development, dissemination, and implementation subcommittee of the american academy of neurology and the American epilepsy society. Neurology. 2017;88:1674–1680.
  • Keller AE, Whitney R, Li S-A, et al. Incidence of sudden unexpected death in epilepsy in children is similar to adults. Neurology. 2018;91:e107–e111.
  • Whitney R, Donner EJ. Risk factors for Sudden Unexpected Death in Epilepsy (SUDEP) and their mitigation. Curr Treat Options Neurol. 2019;21:7.
  • Abdel-Mannan O, Taylor H, Donner EJ, et al. A systematic review of sudden unexpected death in epilepsy (SUDEP) in childhood. Epilepsy Behav. 2019;90:99–106.
  • Donner EJ, Smith CR. Snead OC3. Sudden unexplained death in children with epilepsy. Neurology. 2001;57:430–434.
  • Nilsson L, Farahmand BY, Persson PG, et al. Risk factors for sudden unexpected death in epilepsy: A case-control study. Lancet. 1999;353:888–893.
  • Lhatoo SD, Sander JWAS. Cause-specific mortality in epilepsy. Epilepsia. 2005;46(Suppl 11):36–39.
  • Hesdorffer DC, Tomson T, Benn E, et al. Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia. 2012;53:249–252.
  • Lamberts RJ, Thijs RD, Laffan A, et al. Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia. 2012;53:253–257.
  • George JR, Davis GG. Comparison of anti-epileptic drug levels in different cases of sudden death. J Forensic Sci. 1998;43:598–603.
  • Clark D, Riney K. A population-based post mortem study of sudden unexpected death in epilepsy. J Clin Neurosci. 2016;23:58–62.
  • Ficker DM, So EL, Shen WK, et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology. 1998;51:1270–1274.
  • Thurman DJ, Hesdorffer DC, French JA. Sudden unexpected death in epilepsy: assessing the public health burden. Epilepsia. 2014;55:1479–1485.
  • Tomson T, Sveinsson O, Carlsson S, et al. Evolution over time of SUDEP incidence: A nationwide population-based cohort study. Epilepsia. 2018;59:e120–e124.
  • Tomson T, Nashef L, Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurol. 2008;7:1021–1031.
  • Hebel JM, Surges R, Stodieck SRG, et al. SUDEP following the second seizure in new-onset epilepsy due to limbic encephalitis. Seizure. 2018;62:124–126.
  • Verducci C, Hussain F, Donner E, et al. SUDEP in the North American SUDEP registry: the full spectrum of epilepsies. Neurology. 2019;93:e227–e236.
  • DeGiorgio CM, Curtis A, Hertling D, et al. Sudden unexpected death in epilepsy: risk factors, biomarkers, and prevention. Acta Neurol Scand. 2019;139:220–230.
  • Doherty MJ. The sudden death of patsy custis, or george Washington on sudden unexplained death in epilepsy. Epilepsy Behav. 2004;5:598–600.
  • Langan Y, Nashef L, Sander J. Sudden unexpected death in epilepsy: a series of witnessed deaths. J Neurol Neurosurg Psychiatry. 2000;68:211–213.
  • Tomson T, Walczak T, Sillanpaa M, et al. Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia. 2005;46(Suppl 11):54–61.
  • Ryvlin P, Nashef L, Lhatoo SD, et al. Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): A retrospective study. Lancet Neurol. 2013;12:966–977.
  • Pensel MC, Surges R. Sudden, unexpected death in epilepsy: mechanisms and preventive strategies. Klin Neurophysiol. 2018;49:133–142.
  • Surges R, Strzelczyk A, Scott CA, et al. Postictal generalized electroencephalographic suppression is associated with generalized seizures. Epilepsy Behav. 2011;21:271–274.
  • Tao JX, Yung I, Lee A, et al. Tonic phase of a generalized convulsive seizure is an independent predictor of postictal generalized EEG suppression. Epilepsia. 2013;54:858–865.
  • Alexandre V, Mercedes B, Valton L, et al. Risk factors of postictal generalized EEG suppression in generalized convulsive seizures. Neurology. 2015;85:1598–1603.
  • Peng W, Danison JL, Seyal M. Postictal generalized EEG suppression and respiratory dysfunction following generalized tonic-clonic seizures in sleep and wakefulness. Epilepsia. 2017;58:1409–1414.
  • Marchi A, Giusiano B, King M, et al. Postictal electroencephalographic (EEG) suppression: a stereo-EEG study of 100 focal to bilateral tonic-clonic seizures. Epilepsia. 2019;60:63–73.
  • Lhatoo SD, Faulkner HJ, Dembny K, et al. An electroclinical case-control study of sudden unexpected death in epilepsy. Ann Neurol. 2010;68:787–796.
  • Lamberts RJ, Gaitatzis A, Sander JW, et al. Postictal generalized EEG suppression: an inconsistent finding in people with multiple seizures. Neurology. 2013;81:1252–1256.
  • Semmelroch M, Elwes RDC, Lozsadi DA, et al. Retrospective audit of postictal generalized EEG suppression in telemetry. Epilepsia. 2012;53:e21–e24.
  • Seyal M, Hardin KA, Bateman LM. Postictal generalized EEG suppression is linked to seizure-associated respiratory dysfunction but not postictal apnea. Epilepsia. 2012;53:825–831.
  • Seyal M, Bateman LM, Li C-S. Impact of periictal interventions on respiratory dysfunction, postictal EEG suppression, and postictal immobility. Epilepsia. 2013;54:377–382.
  • Kuo J, Zhao W, Li C-S, et al. Postictal immobility and generalized EEG suppression are associated with the severity of respiratory dysfunction. Epilepsia. 2016;57:412–417.
  • Altenmüller D-M, Schulze-Bonhage A, Elger CE, et al. Local brain activity persists during apparently generalized postictal EEG suppression. Epilepsy Behav. 2016;62:218–224.
  • Bateman LM, Mendiratta A, Liou J-Y, et al. Postictal clinical and electroencephalographic activity following intracranially recorded bilateral tonic-clonic seizures. Epilepsia. 2019;60:74–84.
  • Aiba I, Noebels JL. Spreading depolarization in the brainstem mediates sudden cardiorespiratory arrest in mouse SUDEP models. Sci Transl Med. 2015;7:282ra46.
  • Bateman LM, Li C-S, Seyal M. Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors. Brain. 2008;131:3239–3245.
  • Seyal M, Bateman LM, Albertson TE, et al. Respiratory changes with seizures in localization-related epilepsy: analysis of periictal hypercapnia and airflow patterns. Epilepsia. 2010;51:1359–1364.
  • Singh K, Katz ES, Zarowski M, et al. Cardiopulmonary complications during pediatric seizures: A prelude to understanding SUDEP. Epilepsia. 2013;54:1083–1091.
  • Vilella L, Lacuey N, Hampson JP, et al. Incidence, recurrence, and risk factors for peri-ictal central apnea and sudden unexpected death in epilepsy. Front Neurol. 2019;10:166.
  • Vilella L, Lacuey N, Hampson JP, et al. Postconvulsive central apnea as a biomarker for sudden unexpected death in epilepsy (SUDEP). Neurology. 2019;92:e171–e182.
  • King-Stephens D. Biomarkers for SUDEP: are we there yet? Epilepsy Curr. 2019;19:231–233.
  • Buchanan GF. Impaired CO2-induced arousal in SIDS and SUDEP. Trends Neurosci. 2019;42:242–250.
  • Richerson GB, Buchanan GF. The serotonin axis: shared mechanisms in seizures, depression, and SUDEP. Epilepsia. 2011;52(Suppl 1):28–38.
  • Tupal S, Faingold CL. Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice. Epilepsia. 2006;47:21–26.
  • Tecott LH, Sun LM, Akana SF, et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 1995;374:542–546.
  • Patodia S, Somani A, O’Hare M, et al. The ventrolateral medulla and medullary raphe in sudden unexpected death in epilepsy. Brain. 2018;141:1719–1733.
  • Murugesan A, Rani MRS, Vilella L, et al. Postictal serotonin levels are associated with peri-ictal apnea. Neurology. 2019;93:e1485–e1494
  • Murugesan A, Rani MRS, Hampson J, et al. Serum serotonin levels in patients with epileptic seizures. Epilepsia. 2018;59:e91–e97.
  • Bateman LM, Li C-S, Lin T-C, et al. Serotonin reuptake inhibitors are associated with reduced severity of ictal hypoxemia in medically refractory partial epilepsy. Epilepsia. 2010;51:2211–2214.
  • Lacuey N, Martins R, Vilella L, et al. The association of serotonin reuptake inhibitors and benzodiazepines with ictal central apnea. Epilepsy Behav. 2019;98:73–79.
  • McCarter AR, Timm PC, Shepard PW, et al. Obstructive sleep apnea in refractory epilepsy: a pilot study investigating frequency, clinical features, and association with risk of sudden unexpected death in epilepsy. Epilepsia. 2018;59:1973–1981.
  • Kennedy JD, Hardin KA, Parikh P, et al. Pulmonary edema following generalized tonic clonic seizures is directly associated with seizure duration. Seizure. 2015;27:19–24.
  • Mahdavi Y, Surges R, Nikoubashman O, et al. Neurogenic pulmonary edema following seizures: A retrospective computed tomography study. Epilepsy Behav. 2019;94:112–117.
  • Kloster R, Engelskjøn T. Sudden unexpected death in epilepsy (SUDEP): A clinical perspective and a search for risk factors. J Neurol Neurosurg Psychiatry. 1999;67:439–444.
  • Middleton O, Atherton D, Bundock E, et al. National association of medical examiners position paper: recommendations for the investigation and certification of deaths in people with epilepsy. Epilepsia. 2018;59:530–543.
  • Liebenthal JA, Wu S, Rose S, et al. Association of prone position with sudden unexpected death in epilepsy. Neurology. 2015;84:703–709.
  • Surges R, Walker MC. Peri-ictal heart rates depend on seizure-type. Seizure. 2010;19:453.
  • Surges R, Scott CA, Walker MC. Enhanced QT shortening and persistent tachycardia after generalized seizures. Neurology. 2010;74:421–426.
  • Surges R, Adjei P, Kallis C, et al. Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: A case-control study. Epilepsia. 2010;51:233–242.
  • Strzelczyk A, Adjei P, Scott CA, et al. Postictal increase in T-wave alternans after generalized tonic-clonic seizures. Epilepsia. 2011;52:2112–2117.
  • van der Lende M, Surges R, Sander JW, et al. Cardiac arrhythmias during or after epileptic seizures. J Neurol Neurosurg Psychiatry. 2016;87:69–74.
  • Duplyakov D, Golovina G, Lyukshina N, et al. Syncope, seizure-induced bradycardia and asystole: two cases and review of clinical and pathophysiological features. Seizure. 2014;23:506–511.
  • Schuele SU, Bermeo AC, Alexopoulos AV, et al. Video-electrographic and clinical features in patients with ictal asystole. Neurology. 2007;69:434–441.
  • Dasheiff RM, Dickinson LJ. Sudden unexpected death of epileptic patient due to cardiac arrhythmia after seizure. Arch Neurol. 1986;43:194–196.
  • Espinosa PS, Lee JW, Tedrow UB, et al. Sudden unexpected near death in epilepsy: malignant arrhythmia from a partial seizure. Neurology. 2009;72:1702–1703.
  • Ferlisi M, Tomei R, Carletti M, et al. Seizure induced ventricular fibrillation: A case of near-SUDEP. Seizure. 2013;22:249–251.
  • Cunnington C, Garg S, Balachandran KP. Seizure-associated takotsubo cardiomyopathy presenting with unheralded ventricular fibrillation. Int J Cardiol. 2012;162:e21–e23.
  • Jeppesen J, Fuglsang-Frederiksen A, Brugada R, et al. Heart rate variability analysis indicates preictal parasympathetic overdrive preceding seizure-induced cardiac dysrhythmias leading to sudden unexpected death in a patient with epilepsy. Epilepsia. 2014;55:e67–e71.
  • Kuttab HI, Harris EA, Tataris KL, et al. Cardiac arrhythmia following an epileptic seizure. Clin Pract Cases Emerg Med. 2019;3:354–356.
  • Surges R, Taggart P, Sander JW, et al. Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death. Epilepsia. 2010;51:738–744.
  • Pang TD, Nearing BD, Krishnamurthy KB, et al. Cardiac electrical instability in newly diagnosed/chronic epilepsy tracked by Holter and ECG patch. Neurology. 2019;93:450–458.
  • Chyou JY, Friedman D, Cerrone M, et al. Electrocardiographic features of sudden unexpected death in epilepsy. Epilepsia. 2016;57:e135–e139.
  • Nass RD, Motloch LJ, Paar V, et al. Blood markers of cardiac stress after generalized convulsive seizures. Epilepsia. 2019;60:201–210.
  • Natelson BH, Suarez RV, Terrence CF, et al. Patients with epilepsy who die suddenly have cardiac disease. Arch Neurol. 1998;55:857–860.
  • Fialho GL, Wolf P, Walz R, et al. Increased cardiac stiffness is associated with autonomic dysfunction in patients with temporal lobe epilepsy. Epilepsia. 2018;59:e85–e90.
  • Devinsky O, Kim A, Friedman D, et al. Incidence of cardiac fibrosis in SUDEP and control cases. Neurology. 2018;91:e55–e61.
  • Lamberts RJ, Blom MT, Wassenaar M, et al. Sudden cardiac arrest in people with epilepsy in the community: circumstances and risk factors. Neurology. 2015;85:212–218.
  • Tomson T, Surges R, Delamont R, et al. Who to target in sudden unexpected death in epilepsy prevention and how? Risk factors, biomarkers, and intervention study designs. Epilepsia. 2016;57(Suppl 1):4–16.
  • Ryvlin P, Cascino GD. Sudden unexpected death in epilepsy patients is often misdiagnosed as sudden cardiac death. Neurology. 2017;89:878–879.
  • Bagnall RD, Crompton DE, Petrovski S, et al. Exome-based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy. Ann Neurol. 2016;79:522–534.
  • Bagnall RD, Crompton DE, Semsarian C. Genetic basis of sudden unexpected death in epilepsy. Front Neurol. 2017;8:348.
  • Neubauer J, Lecca MR, Russo G, et al. Post-mortem whole-exome analysis in a large sudden infant death syndrome cohort with a focus on cardiovascular and metabolic genetic diseases. Eur J Hum Genet. 2017;25:404–409.
  • Nass RD, Hampel KG, Elger CE, et al. Blood Pressure in Seizures and Epilepsy. Front Neurol. 2019;10:501.
  • Hampel KG, Jahanbekam A, Elger CE, et al. Seizure-related modulation of systemic arterial blood pressure in focal epilepsy. Epilepsia. 2016;57:1709–1718.
  • Hampel KG, Elger CE, Surges R. Impaired baroreflex sensitivity after bilateral convulsive seizures in patients with focal epilepsy. Front Neurol. 2017;8:210.
  • Allen LA, Harper RM, Kumar R, et al. Dysfunctional brain networking among autonomic regulatory structures in temporal lobe epilepsy patients at high risk of sudden unexpected death in epilepsy. Front Neurol. 2017;8:544.
  • Allen LA, Harper RM, Lhatoo S, et al. Neuroimaging of Sudden Unexpected Death in Epilepsy (SUDEP): insights from structural and resting-state functional MRI studies. Front Neurol. 2019;10:185.
  • Wandschneider B, Koepp M, Scott C, et al. Structural imaging biomarkers of sudden unexpected death in epilepsy. Brain. 2015;138:2907–2919.
  • Allen LA, Vos SB, Kumar R, et al. Cerebellar, limbic, and midbrain volume alterations in sudden unexpected death in epilepsy. Epilepsia. 2019;60:718–729.
  • Koos BJ, Chau A, Matsuura M, et al. Thalamic locus mediates hypoxic inhibition of breathing in fetal sheep. J Neurophysiol. 1998;79:2383–2393.
  • Koos BJ, Kawasaki Y, Hari A, et al. Electrical stimulation of the posteromedial thalamus modulates breathing in unanesthetized fetal sheep. J Appl Physiol. 2004;96:115–123.
  • Joo EY, Tae WS, Lee MJ, et al. Reduced brain gray matter concentration in patients with obstructive sleep apnea syndrome. Sleep. 2010;33:235–241.
  • Woo MA, Macey PM, Fonarow GC, et al. Regional brain gray matter loss in heart failure. J Appl Physiol. 2003;95:677–684.
  • Wang Z, Zhang Z, Jiao Q, et al. Impairments of thalamic nuclei in idiopathic generalized epilepsy revealed by a study combining morphological and functional connectivity MRI. PLoS ONE. 2012;7:e39701.
  • Huang W, Lu G, Zhang Z, et al. Gray-matter volume reduction in the thalamus and frontal lobe in epileptic patients with generalized tonic-clonic seizures. J Neuroradiol. 2011;38:298–303.
  • Ciumas C, Savic I. Structural changes in patients with primary generalized tonic and clonic seizures. Neurology. 2006;67:683–686.
  • Kimmerly DS, O’Leary DD, Menon RS, et al. Cortical regions associated with autonomic cardiovascular regulation during lower body negative pressure in humans. J Physiol. 2005;569:331–345.
  • Ogren JA, Tripathi R, Macey PM, et al. Regional cortical thickness changes accompanying generalized tonic-clonic seizures. Neuroimage Clin. 2018;20:205–215.
  • Tang Y, An D, Xiao Y, et al. Cortical thinning in epilepsy patients with postictal generalized electroencephalography suppression. Eur J Neurol. 2019;26:191–197.
  • Mueller SG, Bateman LM, Laxer KD. Evidence for brainstem network disruption in temporal lobe epilepsy and sudden unexplained death in epilepsy. Neuroimage Clin. 2014;5:208–216.
  • Ryvlin P, Rheims S, Lhatoo SD. Risks and predictive biomarkers of sudden unexpected death in epilepsy patient. Curr Opin Neurol. 2019;32:205–212.
  • Shankar R, Walker M, McLean B, et al. Steps to prevent SUDEP: the validity of risk factors in the SUDEP and seizure safety checklist: a case control study. J Neurol. 2016;263:1840–1846.
  • Sveinsson O, Andersson T, Mattsson P, et al. Clinical risk factors in SUDEP: A nationwide population-based case-control study. Neurology. 2020;94:e419–e429.
  • Shankar R, Ashby S, McLean B, et al. Bridging the gap of risk communication and management using the SUDEP and seizure safety checklist. Epilepsy Behav. 2020;103:106419.
  • Lowerison MW, Josephson CB, Jetté N, et al. Association of levels of specialized care with risk of premature mortality in patients with epilepsy. JAMA Neurol. 2019. DOI:10.1001/jamaneurol.2019.2268.
  • Duncan S, Brodie MJ. Sudden unexpected death in epilepsy. Epilepsy Behav. 2011;21:344–351.
  • Shorvon S, Tomson T. Sudden unexpected death in epilepsy. Lancet. 2011;378:2028–2038.
  • Surges R, Sander JW. Sudden unexpected death in epilepsy: mechanisms, prevalence, and prevention. Curr Opin Neurol. 2012;25:201–207.
  • Ryvlin P, Cucherat M, Rheims S. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol. 2011;10:961–968.
  • Rheims S, Ryvlin P. Pharmacotherapy for tonic-clonic seizures. Expert Opin Pharmacother. 2014;15:1417–1426.
  • Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE study group. Neurology. 1996;46:1678–1683.
  • Tang L, Ge L, Wu W, et al. Lamotrigine versus valproic acid monotherapy for generalised epilepsy: A meta-analysis of comparative studies. Seizure. 2017;51:95–101.
  • Slater J, Chung S, Huynh L, et al. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: meta-analysis of pivotal trials. Epilepsy Res. 2018;143:120–129.
  • Timmings PL. Sudden unexpected death in epilepsy: is carbamazepine implicated? Seizure. 1998;7:289–291.
  • Langan Y, Nashef L, Sander JW. Case-control study of SUDEP. Neurology. 2005;64:1131–1133.
  • Hitiris N, Suratman S, Kelly K, et al. Sudden unexpected death in epilepsy: a search for risk factors. Epilepsy Behav. 2007;10:138–141.
  • Aurlien D, Gjerstad L, Taubøll E. The role of antiepileptic drugs in sudden unexpected death in epilepsy. Seizure. 2016;43:56–60.
  • Auerbach DS, McNitt S, Gross RA, et al. Genetic biomarkers for the risk of seizures in long QT syndrome. Neurology. 2016;87:1660–1668.
  • Goldman AM, Glasscock E, Yoo J, et al. Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death. Sci Transl Med. 2009;1:2ra6.
  • Johnson JN, Hofman N, Haglund CM, et al. Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology. 2009;72:224–231.
  • Heron SE, Hernandez M, Edwards C, et al. Neonatal seizures and long QT syndrome: a cardiocerebral channelopathy? Epilepsia. 2010;51:293–296.
  • González A, Aurlien D, Haugaa KH, et al. Epilepsy in patients with long QT syndrome type 1: A Norwegian family. Epilepsy Behav Case Rep. 2018;10:118–121.
  • González A, Aurlien D, Larsson PG, et al. Seizure-like episodes and EEG abnormalities in patients with long QT syndrome. Seizure. 2018;61:214–220.
  • González A, Aurlien D, Larsson PG, et al. Corrigendum to “Seizure-like episodes and EEG abnormalities in patients with long QT syndrome” Seizure 61 (2018) 214-220. Seizure. 2019;69:304.
  • Schwartz PJ. The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med. 2006;259:39–47.
  • Timmings PL. Sudden unexpected death in epilepsy: a local audit. Seizure. 1993;2:287–290.
  • Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia. 1995;36(Suppl 2):S2–S12.
  • Guerrini R, Dravet C, Genton P, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia. 1998;39:508–512.
  • Crespel A, Genton P, Berramdane M, et al. Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology. 2005;65:762–764.
  • Witchel HJ, Hancox JC. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current. Clin Exp Pharmacol Physiol. 2000;27:753–766.
  • Redfern WS, Carlsson L, Davis AS, et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003;58:32–45.
  • Danielsson BR, Lansdell K, Patmore L, et al. Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents. Epilepsy Res. 2005;63:17–25.
  • Aurlien D, Taubøll E, Gjerstad L. Lamotrigine in idiopathic epilepsy - increased risk of cardiac death? Acta Neurol Scand. 2007;115:199–203.
  • Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270:2590–2597.
  • Lehmann MH, Hardy S, Archibald D, et al. JTc prolongation with d,l-sotalol in women versus men. Am J Cardiol. 1999;83:354–359.
  • Aurlien D, Larsen JP, Gjerstad L, et al. Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: A nested, case-control study. Epilepsia. 2012;53:258–266.
  • Hesdorffer DC, Tomson T, Benn E, et al. Combined analysis of risk factors for SUDEP. Epilepsia. 2011;52:1150–1159.
  • Mohanraj R, Brodie MJ. Pharmacological outcomes in newly diagnosed epilepsy. Epilepsy Behav. 2005;6:382–387.
  • Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369:1016–1026.
  • Tomson T, Hirsch LJ, Friedman D, et al. Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials. Epilepsia. 2013;54:135–140.
  • Sabers A, Buchholt JM, Uldall P, et al. Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res. 2001;47:151–154.
  • Sabers A, Ohman I, Christensen J, et al. Oral contraceptives reduce lamotrigine plasma levels. Neurology. 2003;61:570–571.
  • Sidhu J, Job S, Singh S, et al. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol. 2006;61:191–199.
  • Christensen J, Petrenaite V, Atterman J, et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia. 2007;48:484–489.
  • Reisinger TL, Newman M, Loring DW, et al. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav. 2013;29:13–18.
  • Edey S, Moran N, Nashef L. SUDEP and epilepsy-related mortality in pregnancy. Epilepsia. 2014;55:e72–e74.
  • Hemery C, Ryvlin P, Rheims S. Prevention of generalized tonic-clonic seizures in refractory focal epilepsy: a meta-analysis. Epilepsia. 2014;55:1789–1799.
  • Moseley BD, Sperling MR, Asadi-Pooya AA, et al. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: pooled results from three Phase III studies. Epilepsy Res. 2016;127:179–185.
  • Salanova V, Witt T, Worth R, et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology. 2015;84:1017–1025.
  • Sperling MR, Barshow S, Nei M, et al. A reappraisal of mortality after epilepsy surgery. Neurology. 2016;86:1938–1944.
  • Ryvlin P, So EL, Gordon CM, et al. Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapy. Epilepsia. 2018;59:562–572.
  • Devinsky O, Friedman D, Duckrow RB, et al. Sudden unexpected death in epilepsy in patients treated with brain-responsive neurostimulation. Epilepsia. 2018;59:555–561.
  • Surges R, vonWrede R, Porschen T, et al. Knowledge of sudden unexpected death in epilepsy (SUDEP) among 372 patients attending a German tertiary epilepsy center. Epilepsy Behav. 2018;80:360–364.
  • Strzelczyk A, Zschebek G, Bauer S, et al. Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians. Epilepsia. 2016;57:612–620.
  • Gayatri NA, Morrall MCHJ, Jain V, et al. Parental and physician beliefs regarding the provision and content of written sudden unexpected death in epilepsy (SUDEP) information. Epilepsia. 2010;51:777–782.
  • Tonberg A, Harden J, McLellan A, et al. A qualitative study of the reactions of young adults with epilepsy to SUDEP disclosure, perceptions of risks, views on the timing of disclosure, and behavioural change. Epilepsy Behav. 2015;42:98–106.
  • Fong CY, Lim WK, Kong AN, et al. Provision of sudden unexpected death in epilepsy (SUDEP) information among Malaysian parents of children with epilepsy. Epilepsy Behav. 2017;75:6–12.
  • Radhakrishnan DM, Ramanujam B, Srivastava P, et al. Effect of providing sudden unexpected death in epilepsy (SUDEP) information to persons with epilepsy (PWE) and their caregivers-Experience from a tertiary care hospital. Acta Neurol Scand. 2018;138:417–424.
  • van der Lende M, Hesdorffer DC, Sander JW, et al. Nocturnal supervision and SUDEP risk at different epilepsy care settings. Neurology. 2018;91:e1508–e1518.
  • Maguire MJ, Jackson CF, Marson AG, et al. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP). Cochrane Database Syst Rev. 2016;7:CD011792.
  • Catcheside PG, Mohtar AA, Reynolds KJ. Airflow resistance and CO2 rebreathing properties of anti-asphyxia pillows designed for epilepsy. Seizure. 2014;23:462–467.
  • Ryvlin P, Ciumas C, Wisniewski I, et al. Wearable devices for sudden unexpected death in epilepsy prevention. Epilepsia. 2018;59(Suppl 1):61–66.
  • Narechania AP, Garić II, Sen-Gupta I, et al. Assessment of a quasi-piezoelectric mattress monitor as a detection system for generalized convulsions. Epilepsy Behav. 2013;28:172–176.
  • Beniczky S, Polster T, Kjaer TW, et al. Detection of generalized tonic-clonic seizures by a wireless wrist accelerometer: A prospective, multicenter study. Epilepsia. 2013;54:e58–e61.
  • Poh M-Z, Loddenkemper T, Reinsberger C, et al. Convulsive seizure detection using a wrist-worn electrodermal activity and accelerometry biosensor. Epilepsia. 2012;53:e93–e97.
  • Arends J, Thijs RD, Gutter T, et al. Multimodal nocturnal seizure detection in a residential care setting: A long-term prospective trial. Neurology. 2018;91:e2010–e2019.
  • Jeppesen J, Fuglsang-Frederiksen A, Johansen P, et al. Seizure detection based on heart rate variability using a wearable electrocardiography device. Epilepsia. 2019;60:2105–2113.
  • Swinghamer J, Devinsky O, Friedman D. Can post-ictal intervention prevent sudden unexpected death in epilepsy? A report of two cases. Epilepsy Behav. 2012;24:377–379.
  • Walczak TS, Leppik IE, D’Amelio M, et al. Incidence and risk factors in sudden unexpected death in epilepsy: A prospective cohort study. Neurology. 2001;56:519–525.
  • DeGiorgio CM, Miller P, Meymandi S, et al. RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory. Epilepsy Behav. 2010;19:78–81.
  • Novak JL, Miller PR, Markovic D, et al. Risk Assessment for Sudden Death in Epilepsy: the SUDEP-7 Inventory. Front Neurol. 2015;6:252.
  • Shankar R, Cox D, Jalihal V, et al. Sudden unexpected death in epilepsy (SUDEP): development of a safety checklist. Seizure. 2013;22:812–817.
  • Coll M, Oliva A, Grassi S, et al. Update on the genetic basis of sudden unexpected death in epilepsy. Int J Mol Sci. 2019;20. DOI:10.3390/ijms20081979.
  • Abbasi B, Goldenholz DM. Machine learning applications in epilepsy. Epilepsia. 2019;60:2037–2047.
  • Mormann F, Andrzejak RG, Elger CE, et al. Seizure prediction: the long and winding road. Brain. 2007;130:314–333.
  • Kuhlmann L, Lehnertz K, Richardson MP, et al. Seizure prediction - ready for a new era. Nat Rev Neurol. 2018;14:618–630.
  • Gadhoumi K, Lina J-M, Mormann F, et al. Seizure prediction for therapeutic devices: A review. J Neurosci Methods. 2016;260:270–282.
  • Shokouh Alaei H, Khalilzadeh MA, Gorji A. Optimal selection of SOP and SPH using fuzzy inference system for on-line epileptic seizure prediction based on EEG phase synchronization. Australas Phys Eng Sci Med. 2019;42:1049–1068.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.